FDA approves first drug for treating spinal muscular dystrophy

On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares